News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
318 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39672)
2015 (44431)
2016 (38329)
2017 (37186)
2018 (39119)
2019 (51334)
2020 (57662)
2021 (58720)
2022 (53927)
2023 (42564)
2024 (37440)
2025 (33091)
2026 (29199)
Month
January (3217)
February (3391)
March (3462)
April (3660)
May (4506)
June (2887)
July (2191)
August (2499)
September (2720)
October (3233)
November (3383)
December (2291)
Day
1 (211)
2 (275)
3 (98)
4 (3)
5 (3)
6 (223)
7 (318)
8 (290)
9 (316)
10 (100)
11 (3)
12 (1)
13 (228)
14 (252)
15 (220)
16 (160)
17 (81)
18 (5)
19 (7)
20 (145)
21 (204)
22 (196)
23 (239)
24 (73)
25 (4)
27 (19)
28 (232)
29 (269)
30 (238)
31 (93)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
27
28
29
30
31
Business
Nevro Reports First-Quarter 2024 Financial Results
Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic pain, today reported its first quarter 2024 financial results.
May 7, 2024
·
19 min read
Biotech Bay
Arcellx to Participate in Two Upcoming May 2024 Investor Conferences
Arcellx, Inc. announced that management will participate in two upcoming investor conferences.
May 7, 2024
·
2 min read
Business
Quanterix Releases Financial Results for the First Quarter of 2024
Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced financial results for the first quarter ended March 31, 2024.
May 7, 2024
·
11 min read
Business
STAAR Surgical Announces Milestone Strategic Agreement in U.S. with IQ Laser Vision
STAAR Surgical Company announces another milestone achieved on its U.S. Highway 93 go-to-market program – a strategic agreement with IQ Laser Vision, a leader in providing clear vision to clients with locations across California and Texas, and a top EVO ICL practice in North America.
May 7, 2024
·
9 min read
Biotech Bay
Exelixis to Webcast Fireside Chats as Part of Investor Conferences in May 2024
Exelixis, Inc. announced that members of the company’s management team will participate in fireside chats at the following investor conferences in May.
May 7, 2024
·
2 min read
Business
Gossamer Bio Announces First Quarter 2024 Financial Results and Provides Business Update
Gossamer Bio, Inc. announced its financial results for the first quarter ended March 31, 2024, and provided a business update.
May 7, 2024
·
9 min read
Business
ATEC Reports First Quarter 2024 Financial Results and Raises Full-Year Guidance
Alphatec Holdings, Inc., a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced financial results for the quarter ended March 31, 2024, and recent corporate highlights.
May 7, 2024
·
12 min read
Business
Ligand Reports First Quarter 2024 Financial Results
Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today reported financial results for the three months ended March 31, 2024, and provided an operating forecast and business updates.
May 7, 2024
·
22 min read
Business
Janux Therapeutics Reports First Quarter 2024 Financial Results and Business Highlights
Janux Therapeutics, Inc. (Nasdaq: JANX) (Janux) today reported financial results for the first quarter ended March 31, 2024 and provided a business update.
May 7, 2024
·
7 min read
Cheshire-based global b2b PR and marketing agency The Scott Partnership achieves The King’s Award for Enterprise for International Trade
Global independent science and technology b2b communications agency, The Scott Partnership
May 7, 2024
·
3 min read
Previous
28 of 32
Next